» Download Public Reports
11 reports
- Company report
- January 2010
- 25 pages
... And deliverability to the proven combination of abluminal ba9 drug coating page9 china update Jwms continues to contribute positively to operating results: Revenues of us$ 16.6 Million Net income of us$ 12 ...
November 2011
... Countries Growing number of acute and chronic diseases Accelerating pace in drug development Growth in biotech drugs and generics Outsourcing trend of drug delivery and primary packaging ...
December 2011
... Our strategy is to focus on our polymer therapeutic program for the treatment of cancer while continuing to develop technologies such as coboral-mediated oral drug delivery and cobacyte-mediated tumor ...
December 2011
... To become the first orally delivered peptide approved by the fda; approval (if any) of ostora will further val the company S oral peptide drug delivery technology platform; the company S investment ...
January 2009
... To technology inhaled products transdermal products More complex drug delivery technologies are mainly concentrated in developed markets such as the us, germany and australia. Cost, access to technology ...
May 2010
... In 2010 cn medical equipment sector: solid demand for drug-eluting stent system, lepu S outlook good strong drug-eluting stent system market potential on rising incidence rate of cardiovascular ...
May 2010
... Mr. Ren dequan served as deputy director of state administration of trional chinese medicine, deputy director of state drug administration, deputy director of state food and drug administration ...
July 2012
... Proof operation of a simple mechanically-driven device is easily adoptable; proof of value yet to be demonstrated addressable market size 5 pulmonary drug deliveries are worth tens of billions u.S. Dollars ...
August 2010
... Business 6 1) value added drug delivery devices catered for biomedicine (drug & device) growing demands of value added drug delivery device catered for biomedicine growing demands of value added drug ...